Clinicopathological significance of caspase-8 and caspase-10 expression in rectal cancer

Oncology

Volumn 74, Issue 3-4, 2008, Pages 229-236

  Xu, Bing ^a   Zhou, Zong Guang ^a   Li, Yuan ^a   Wang, Ling ^a   Yang, Lie ^a   Zhou, Bin ^a   Liu, Hai Yi ^a   Song, Jun Min ^a   Zeng, Yu Jian ^a   Wang, Rong ^a   Shen, Xiao Gang ^a   Sun, Xiao Feng ^b  

^a SICHUAN UNIVERSITY   (China)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Apoptosis; Caspase 10; Caspase 8; Immunohistochemistry; Rectal neoplasm; RT PCR

Indexed keywords

CASPASE 10; CASPASE 8; MESSENGER RNA;

ADULT; ARTICLE; CANCER SURGERY; CARCINOGENESIS; CLINICAL EVALUATION; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM ADENOMA; RECTUM CARCINOMA; RECTUM MUCOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; UPREGULATION;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADENOMA; CARCINOMA, SIGNET RING CELL; CARCINOMA, SQUAMOUS CELL; CASPASE 10; CASPASE 8; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM;

EID: 49849094851     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151392     Document Type: Article

References (32)

1. Boyle P, Ferlay J: Cancer incidence and mortality in Europe. Ann Oncol 2005;16:481-488.
2. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000;100:57-70.
3. Jin ZY, El-Deiry WS: Overview of cell death signaling pathways. Cancer Biol Ther 2005;4:139-163.
4. Li HL, Zhu H, Xu CJ, Yuan JY: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998;94:491-501.
5. Luo X, Budihardjo I, Zou H, Slaughter C, Wang XD: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998;94:481-490.
6. Milhas D, Cuvillier O, Therville N, Clave P, Thomsen M, Levade T, Benoist H, Segui B: Caspase-10 triggers Bid cleavage and caspase cascade activation in FasL-induced apoptosis. J Biol Chem 2005;280:19836-19842.
7. Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES: In vitro activation of CPP32 and MCH3 by MCH4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 1996;93:7464-7469.
8. Grenet J, Teitz T, Wei T, Valentine V, Kidd VJ: Structure and chromosome localization of the human CASP8 gene. Gene 1999;226:225-232.
9. Wang J, Chun HJ, Wong W, Spencer DM, Lenardo MJ: Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci USA 2001;98:13884-13888.
10. Kischkel FC, Lawrence DA, Tinel A, LeBlanc H, Virmani A, Schow P, Gazdar A, Blenis J, Arnott D, Ashkenazi A: Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 2001;276:46639-46646.
11. Hopkins-Donaldson S, Bodmer JL, Bourloud KB, Brognara CB, Tschopp J, Gross N: Loss of caspase-8 expression in neuroblastoma is related to malignancy and resistance to TRAIL-induced apoptosis. Med Pediatr Oncol 2000;35:608-611.
12. Harada K, Toyooka S, Shivapurkar N, Maitra A, Reddy JL, Matta H, Miyajima K, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Chaudhary PM, Gazdar AF: Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res 2002;62:5897-5901.
13. Shin MS, Kim HS, Kang CS, Park WS, Kim SY, Lee SN, Lee JH, Park JY, Jang JJ, Kim CW, Kim SH, Lee JY, Yoo NJ, Lee SH: Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 2002;99:4094-4099.
14. Shin MS, Kim HS, Lee SH, Lee JW, Song YH, Kim YS, Park WS, Kim SY, Lee SN, Park JY, Lee JH, Xiao W, Jo KH, Wang YP, Lee KY, Park YG, Kim SH, Lee JY, Yoo NJ: Alterations of Fas-pathway genes associated with nodal metastasis in non-small cell lung cancer. Oncogene 2002;21:4129-4136.
15. Park WS, Lee JH, Shin MS, Park JY, Kim HS, Lee JH, Kim YS, Lee SN, Xiao W, Park CH, Lee SH, Yoo NJ, Lee JY: Inactivating mutations of the caspase-10 gene in gastric cancer. Oncogene 2002;21:2919-2925.
16. Pingoud-Meier C, Lang D, Janss AJ, Rorke LB, Phillips PC, Shalaby T, Grotzer MA: Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. Clin Cancer Res 2003;9:6401-6409.
17. Teitz T, Lahti J, Kidd VJ: Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell death. J Mol Med 2001;79:428-436.
18. Bond JH: Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 2000;95:3053-3063.
19. Yang L, Zhou ZG, Luo HZ, Zhou B, Xia QJ, Tian C: Quantitative analysis of PPAR delta mRNA by real-time RT-PCR in 86 rectal cancer tissues. Eur J Surg Oncol 2006;32:181-185.
20. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:2002-2007.
21. Mygind T, Birkelund S, Birkebaek N, Oestergaard L, Jensen J, Christiansen G: Determination of PCR efficiency in chelex-100 purified clinical samples and comparison of real-time quantitative PCR and conventional PCR for detection of Chlamydia pneumoniae. BMC Microbiol 2002;2:17-24.
22. Fong PY, Xue WC, Ngan HYS, Chiu PM, Chan KYK, Tsao SW, Cheung ANY: Caspase activity is downregulated in choriocarcinoma: a cDNA array differential expression study. J Clin Pathol 2006;59:179-183.
23. Pfaffl MW, Horgan GW, Dempfle L: Relative expression software tool (REST) for groupwise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30:e36.
24. Kang TB, Ben-Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A, Waisman A, Brenner O, Haffner R, Gustafsson E, Ramakrishnan P, Lapidot T, Wallach D: Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol 2004;173:2976-2984.
25. Falk M, Ussat S, Reiling N, Wesch D, Kabelitz D, Adam-Klages S: Caspase inhibition blocks human T cell proliferation by suppressing appropriate regulation of IL-2, CD25, and cell cycle-associated proteins. J Immunol 2004;173:5077-5085.
26. Olson NE, Graves JD, Shu GL, Ryan EJ, Clark EA: Caspase activity is required for stimulated B lymphocytes to enter cell cycle. J Immunol 2003;170:6065-6072.
27. Kim HS, Lee JW, Soung YH, Park WS, Kim SY, Lee JH, Park JY, Cho YG, Kim CJ, Jeong SW, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH: Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 2003;125:708-715.
28. Graudens E, Boulanger V, Mollard C, Mariage-Samson R, Barlet X, Grémy G, Couillault C, Lajémi M, Piatier-Tonneau D, Zaborski P, Eveno E, Auffray C, Imbeaud S: Deciphering cellular states of innate tumor drug responses. Genome Biol 2006;7:R19.
29. Watanabe T, Kobunai T, Toda E, Yamamoto Y, Kanazawa T, Kazama Y, Tanaka J, Tanaka T, Konishi T, Okayama Y, Sugimoto Y, Oka T, Sasaki S, Muto T, Nagawa H: Distal colorectal cancers with microsatellite instability (MSI) display distinct gene expression profiles that are different from proximal MSI cancers. Cancer Res 2006;66:9804-9808.
30. Koinuma K, Yamashita Y, Liu W, Hatanaka H, Kurashina K, Wada T, Takada S, Kaneda R, Choi YL, Fujiwara SI, Miyakura Y, Nagai H, Mano H: Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability. Oncogene 2006;25:139-146.
31. Vincenz C, Dixit VM: Fas-associated-death domain protein interleukin-1-beta-converting enzyme 2 (FLICE2), an ICE/CED-3 homologue, is proximally involved in CD95-and p55-mediated death signaling. J Biol Chem 1997;272:6578-6583.
32. Palmerini F, Devilard E, Jarry A, Birg F, Xerri L: Caspase 7 downregulation as an immunohistochemical marker of colonic carcinoma. Hum Pathol 2001;32:461-467.